Alkermes plc. Amortization of Intangible Assets
Alkermes plc. (ALKS) reported Amortization of Intangible Assets of $22.59 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-07-28
- Alkermes plc. amortization of intangible assets for the quarter ending 2026-06-30 was $22.59M.
- Alkermes plc. amortization of intangible assets for the quarter ending 2026-03-31 was $11.68M.
- Alkermes plc. amortization of intangible assets for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Alkermes plc. amortization of intangible assets for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Alkermes plc. amortization of intangible assets for fiscal 2024 was $1.10M, a 96.92% decline from fiscal 2023.
- Alkermes plc. amortization of intangible assets for fiscal 2023 was $35.69M, a 1.85% decline from fiscal 2022.
- Alkermes plc. amortization of intangible assets for fiscal 2022 was $36.36M, a 4.68% decline from fiscal 2021.
- Alkermes plc. amortization of intangible assets for fiscal 2021 was $38.15M, a 3.31% decline from fiscal 2020.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $22.59M 10-Q · filed 2026-07-28 | $34.26M 10-Q · filed 2026-07-28 | |||
| 2026-03-31 | $11.68M 10-Q · filed 2026-05-05 | ||||
| 2025-09-30 | $0.00 10-Q · filed 2025-10-28 | $0.00 derived: sum of 2 quarters · filed 2026-07-28 | $0.00 10-Q · filed 2025-10-28 | $14.00K derived: sum of 4 quarters · filed 2026-07-28 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-07-28 | $0.00 10-Q · filed 2026-07-28 | $14.00K derived: sum of 3 quarters · filed 2026-07-28 | $28.00K derived: sum of 4 quarters · filed 2026-07-28 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-05 | $14.00K derived: sum of 2 quarters · filed 2026-05-05 | $28.00K derived: sum of 3 quarters · filed 2026-05-05 | $42.00K derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $28.00K derived: sum of 2 quarters · filed 2026-02-25 | $42.00K derived: sum of 3 quarters · filed 2026-02-25 | $1.10M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $14.00K 10-Q · filed 2025-10-28 | $28.00K derived: sum of 2 quarters · filed 2025-10-28 | $1.09M 10-Q · filed 2025-10-28 | $10.08M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-06-30 | $14.00K 10-Q · filed 2025-07-29 | $1.07M 10-Q · filed 2025-07-29 | $10.07M derived: sum of 3 quarters · filed 2026-02-25 | $19.06M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-03-31 | $1.06M 10-Q · filed 2025-05-01 | $10.05M derived: sum of 2 quarters · filed 2026-02-25 | $19.05M derived: sum of 3 quarters · filed 2026-02-25 | $27.95M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2023-12-31 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $17.99M derived: sum of 2 quarters · filed 2026-02-25 | $26.89M derived: sum of 3 quarters · filed 2026-02-25 | $35.69M 10-K · filed 2026-02-25 | |
| 2023-09-30 | $8.99M 10-Q · filed 2024-10-24 | $17.89M derived: sum of 2 quarters · filed 2024-10-24 | $26.69M 10-Q · filed 2024-10-24 | $35.86M derived: sum of 4 quarters · filed 2025-02-12 | |
| 2023-06-30 | $8.90M 10-Q · filed 2024-07-24 | $17.70M 10-Q · filed 2024-07-24 | $26.86M derived: sum of 3 quarters · filed 2025-02-12 | $36.03M derived: sum of 4 quarters · filed 2025-02-12 | |
| 2023-03-31 | $8.80M 10-Q · filed 2024-05-01 | $17.96M derived: sum of 2 quarters · filed 2025-02-12 | $27.13M derived: sum of 3 quarters · filed 2025-02-12 | $36.20M derived: sum of 4 quarters · filed 2025-02-12 | |
| 2022-12-31 | $9.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $18.33M derived: sum of 2 quarters · filed 2025-02-12 | $27.40M derived: sum of 3 quarters · filed 2025-02-12 | $36.36M 10-K · filed 2025-02-12 | |
| 2022-09-30 | $9.17M 10-Q · filed 2023-10-25 | $18.23M derived: sum of 2 quarters · filed 2023-10-25 | $27.20M 10-Q · filed 2023-10-25 | $36.81M derived: sum of 4 quarters · filed 2024-02-21 | |
| 2022-06-30 | $9.07M 10-Q · filed 2023-07-26 | $18.03M 10-Q · filed 2023-07-26 | $27.65M derived: sum of 3 quarters · filed 2024-02-21 | $37.26M derived: sum of 4 quarters · filed 2024-02-21 | |
| 2022-03-31 | $8.97M 10-Q · filed 2023-04-26 | $18.58M derived: sum of 2 quarters · filed 2024-02-21 | $28.20M derived: sum of 3 quarters · filed 2024-02-21 | $37.71M derived: sum of 4 quarters · filed 2024-02-21 | |
| 2021-12-31 | $9.62M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $19.23M derived: sum of 2 quarters · filed 2024-02-21 | $28.74M derived: sum of 3 quarters · filed 2024-02-21 | $38.15M 10-K · filed 2024-02-21 | |
| 2021-09-30 | $9.62M 10-Q · filed 2022-11-02 | $19.13M derived: sum of 2 quarters · filed 2022-11-02 | $28.53M 10-Q · filed 2022-11-02 | $38.45M derived: sum of 4 quarters · filed 2023-02-16 | |
| 2021-06-30 | $9.51M 10-Q · filed 2022-07-27 | $18.92M 10-Q · filed 2022-07-27 | $28.83M derived: sum of 3 quarters · filed 2023-02-16 | $38.75M derived: sum of 4 quarters · filed 2023-02-16 | |
| 2021-03-31 | $9.41M 10-Q · filed 2022-04-27 | $19.32M derived: sum of 2 quarters · filed 2023-02-16 | $29.24M derived: sum of 3 quarters · filed 2023-02-16 | $39.13M derived: sum of 4 quarters · filed 2023-02-16 | |
| 2020-12-31 | $9.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $19.83M derived: sum of 2 quarters · filed 2023-02-16 | $29.72M derived: sum of 3 quarters · filed 2023-02-16 | $39.45M 10-K · filed 2023-02-16 | |
| 2020-09-30 | $9.92M 10-Q · filed 2021-10-27 | $19.81M derived: sum of 2 quarters · filed 2021-10-27 | $29.54M 10-Q · filed 2021-10-27 | $39.71M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2020-06-30 | $9.89M 10-Q · filed 2021-07-28 | $19.62M 10-Q · filed 2021-07-28 | $29.79M derived: sum of 3 quarters · filed 2022-02-16 | $39.96M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2020-03-31 | $9.73M 10-Q · filed 2021-04-28 | $19.90M derived: sum of 2 quarters · filed 2022-02-16 | $30.07M derived: sum of 3 quarters · filed 2022-02-16 | $40.13M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2019-12-31 | $10.17M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $20.34M derived: sum of 2 quarters · filed 2022-02-16 | $30.41M derived: sum of 3 quarters · filed 2022-02-16 | $40.36M 10-K · filed 2022-02-16 | |
| 2019-09-30 | $10.17M 10-Q · filed 2020-10-29 | $20.23M derived: sum of 2 quarters · filed 2020-10-29 | $30.19M 10-Q · filed 2020-10-29 | $46.61M derived: sum of 4 quarters · filed 2021-02-11 | |
| 2019-06-30 | $10.06M 10-Q · filed 2020-07-29 | $20.01M 10-Q · filed 2020-07-29 | $36.44M derived: sum of 3 quarters · filed 2021-02-11 | $52.87M derived: sum of 4 quarters · filed 2021-02-11 | |
| 2019-03-31 | $9.95M 10-Q · filed 2020-04-29 | $26.38M derived: sum of 2 quarters · filed 2021-02-11 | $42.80M derived: sum of 3 quarters · filed 2021-02-11 | $59.05M derived: sum of 4 quarters · filed 2021-02-11 | |
| 2018-12-31 | $16.43M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $32.85M derived: sum of 2 quarters · filed 2021-02-11 | $49.10M derived: sum of 3 quarters · filed 2021-02-11 | $65.17M 10-K · filed 2021-02-11 | |
| 2018-09-30 | $16.43M 10-Q · filed 2019-10-23 | $32.67M derived: sum of 2 quarters · filed 2019-10-23 | $48.74M 10-Q · filed 2019-10-23 | $64.38M derived: sum of 4 quarters · filed 2020-02-13 | |
| 2018-06-30 | $16.25M 10-Q · filed 2019-07-25 | $32.32M 10-Q · filed 2019-07-25 | $47.96M derived: sum of 3 quarters · filed 2020-02-13 | $63.60M derived: sum of 4 quarters · filed 2020-02-13 | |
| 2018-03-31 | $16.07M 10-Q · filed 2019-04-25 | $31.71M derived: sum of 2 quarters · filed 2020-02-13 | $47.35M derived: sum of 3 quarters · filed 2020-02-13 | $62.83M derived: sum of 4 quarters · filed 2020-02-13 | |
| 2017-12-31 | $15.64M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $31.29M derived: sum of 2 quarters · filed 2020-02-13 | $46.76M derived: sum of 3 quarters · filed 2020-02-13 | $62.06M 10-K · filed 2020-02-13 | |
| 2017-09-30 | $15.64M 10-Q · filed 2018-10-23 | $31.11M derived: sum of 2 quarters · filed 2018-10-23 | $46.42M 10-Q · filed 2018-10-23 | $61.74M derived: sum of 4 quarters · filed 2019-02-15 | |
| 2017-06-30 | $15.47M 10-Q · filed 2018-07-26 | $30.77M 10-Q · filed 2018-07-26 | $46.10M derived: sum of 3 quarters · filed 2019-02-15 | $61.42M derived: sum of 4 quarters · filed 2019-02-15 | |
| 2017-03-31 | $15.30M 10-Q · filed 2018-04-26 | $30.63M derived: sum of 2 quarters · filed 2019-02-15 | $45.95M derived: sum of 3 quarters · filed 2019-02-15 | $61.10M derived: sum of 4 quarters · filed 2019-02-15 | |
| 2016-12-31 | $15.32M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $30.65M derived: sum of 2 quarters · filed 2019-02-15 | $45.80M derived: sum of 3 quarters · filed 2019-02-15 | $60.96M 10-K · filed 2019-02-15 | |
| 2016-09-30 | $15.32M 10-Q · filed 2017-10-26 | $30.48M derived: sum of 2 quarters · filed 2017-10-26 | $45.64M 10-Q · filed 2017-10-26 | $59.84M derived: sum of 4 quarters · filed 2018-02-16 | |
| 2016-06-30 | $15.16M 10-Q · filed 2017-07-27 | $30.31M 10-Q · filed 2017-07-27 | $44.52M derived: sum of 3 quarters · filed 2018-02-16 | $58.73M derived: sum of 4 quarters · filed 2018-02-16 | |
| 2016-03-31 | $15.16M 10-Q · filed 2017-04-27 | $29.36M derived: sum of 2 quarters · filed 2018-02-16 | $43.57M derived: sum of 3 quarters · filed 2018-02-16 | $57.62M derived: sum of 4 quarters · filed 2018-02-16 | |
| 2015-12-31 | $14.21M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $28.41M derived: sum of 2 quarters · filed 2018-02-16 | $42.47M derived: sum of 3 quarters · filed 2018-02-16 | $57.69M 10-K · filed 2018-02-16 | |
| 2015-09-30 | $14.21M 10-Q · filed 2016-11-02 | $28.26M derived: sum of 2 quarters · filed 2016-11-02 | $43.48M 10-Q · filed 2016-11-02 | $58.72M derived: sum of 4 quarters · filed 2017-02-17 | |
| 2015-06-30 | $14.05M 10-Q · filed 2016-07-28 | $29.27M 10-Q · filed 2016-07-28 | $44.52M derived: sum of 3 quarters · filed 2017-02-17 | $59.76M derived: sum of 4 quarters · filed 2017-02-17 | |
| 2015-03-31 | $15.22M 10-Q · filed 2016-04-28 | $30.46M derived: sum of 2 quarters · filed 2017-02-17 | $45.71M derived: sum of 3 quarters · filed 2017-02-17 | $60.80M derived: sum of 4 quarters · filed 2017-02-17 | |
| 2014-12-31 | $15.24M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $30.49M derived: sum of 2 quarters · filed 2017-02-17 | $45.58M derived: sum of 3 quarters · filed 2017-02-17 | $58.15M 10-K · filed 2017-02-17 | |
| 2014-09-30 | $15.24M 10-Q · filed 2015-10-29 | $30.33M derived: sum of 2 quarters · filed 2015-10-29 | $42.91M 10-Q · filed 2015-10-29 | $55.77M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2014-06-30 | $15.09M 10-Q · filed 2015-07-30 | $27.66M 10-Q · filed 2015-07-30 | $40.52M derived: sum of 3 quarters · filed 2016-02-25 | $53.38M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2014-03-31 | $12.58M 10-Q · filed 2015-04-30 | $25.43M derived: sum of 2 quarters · filed 2016-02-25 | $38.29M derived: sum of 3 quarters · filed 2016-02-25 | $51.00M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2013-12-31 | $12.86M derived: 10-K 9 month − 10-Q 6 month · filed 2016-02-25 | $25.71M derived: sum of 2 quarters · filed 2016-02-25 | $38.43M 10-K · filed 2016-02-25 | $48.75M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2013-09-30 | $12.86M 10-Q · filed 2014-10-29 | $25.57M 10-Q · filed 2013-10-31 | $35.89M 10-Q · filed 2014-10-29 | $46.44M derived: sum of 4 quarters · filed 2014-10-29 | |
| 2013-06-30 | $12.72M 10-Q · filed 2014-07-31 | $23.04M 10-Q · filed 2014-07-31 | $33.59M derived: sum of 3 quarters · filed 2014-07-31 | $44.13M derived: sum of 4 quarters · filed 2014-07-31 | |
| 2013-03-31 | $10.32M 10-Q · filed 2014-04-30 | $20.87M derived: sum of 2 quarters · filed 2014-04-30 | $31.42M derived: sum of 3 quarters · filed 2014-04-30 | $41.85M 10-K · filed 2015-02-24 | |
| 2012-12-31 | $10.55M 10-Q · filed 2013-01-31 | $21.10M derived: sum of 2 quarters · filed 2013-10-31 | $31.53M 10-Q · filed 2013-01-31 | $43.17M derived: sum of 4 quarters · filed 2014-02-27 | |
| 2012-09-30 | $10.55M 10-Q · filed 2013-10-31 | $20.98M 10-Q · filed 2013-10-31 | $32.62M derived: sum of 3 quarters · filed 2014-02-27 | $44.52M derived: sum of 4 quarters · filed 2014-02-27 | |
| 2012-06-30 | $10.43M 10-Q · filed 2013-07-25 | $22.08M derived: sum of 2 quarters · filed 2014-02-27 | $33.97M derived: sum of 3 quarters · filed 2014-02-27 | $35.79M derived: sum of 4 quarters · filed 2014-02-27 | |
| 2012-03-31 | $11.64M derived: 10-KT 12 month − 10-Q 9 month · filed 2014-02-27 | $23.54M derived: sum of 2 quarters · filed 2014-02-27 | $25.36M derived: sum of 3 quarters · filed 2014-02-27 | $25.36M 10-KT · filed 2014-02-27 | $71.16M 10-K · filed 2012-05-18 |
| 2011-12-31 | $11.90M 10-Q · filed 2013-01-31 | $13.71M derived: sum of 2 quarters · filed 2013-01-31 | $13.71M 10-Q · filed 2013-01-31 | ||
| 2011-09-30 | $1.82M 10-Q · filed 2012-11-01 | $1.82M 10-Q · filed 2012-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |